Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Alnylam Pharmace. | 51 | 0 | 0 | 0 | €399.90 | €456.30 | 14.102% |
| Neurocrine Bioscience | 49 | 0 | 2 | 0 | €135.05 | €148.09 | 9.657% |
| Ionis Pharmaceuticals Inc. | 48 | 1 | 2 | 0 | €70.26 | €71.43 | 1.664% |
| Insulet Corp. | 47 | 0 | 17 | 0 | €266.20 | €315.97 | 18.697% |
| Exelixis Inc. | 40 | 0 | 4 | 0 | €38.23 | €40.48 | 5.879% |
| Tenet Healthcare | 40 | 0 | 3 | 0 | €181.00 | €190.72 | 5.372% |
| Jazz Pharmaceuticals plc | 39 | 0 | 5 | 0 | €141.85 | €169.26 | 19.323% |
| Merit Medical Systems | 31 | 0 | 2 | 0 | ? | €95.59 | 34.635% |
| PTC Therapeutics Inc. | 32 | 2 | 1 | 1 | ? | €69.08 | 5.469% |
| Acadia Pharmaceuticals | 27 | 1 | 4 | 0 | €23.52 | €27.38 | 16.408% |
| United Therapeutics | 24 | 1 | 1 | 0 | €415.90 | €480.20 | 15.460% |
| Ultragenyx Pharmaceutical Inc. | 21 | 0 | 3 | 0 | ? | €78.31 | 150.990% |
| Icon plc | 21 | 0 | 0 | 0 | €159.60 | €203.65 | 27.599% |
| Charles River Labs Intl | 19 | 0 | 4 | 0 | €157.30 | €165.88 | 5.453% |
| Halozyme Therapeutics Inc. | 21 | 2 | 3 | 1 | €55.04 | €67.75 | 23.093% |
| Arrowhead Pharmaceuticals Inc. | 19 | 0 | 6 | 0 | €52.26 | €64.41 | 23.255% |
| Masimo Corp. | 17 | 0 | 4 | 0 | €123.10 | €174.29 | 41.584% |
| Repligen Corp. | 18 | 1 | 0 | 0 | €141.15 | €158.80 | 12.502% |
| Alkermes plc | 17 | 0 | 4 | 0 | ? | €38.70 | 54.809% |
| Bio-Techne Corp. | 17 | 0 | 3 | 0 | €54.00 | €60.82 | 12.635% |
| Haemonetics Corp. | 17 | 1 | 3 | 0 | €72.00 | €76.78 | 6.638% |
| Iovance Biotherapeutics Inc. | 17 | 2 | 0 | 0 | €1.90 | €15.72 | 727.384% |
| LivaNova plc | 15 | 0 | 3 | 0 | ? | €57.19 | 4.939% |
| Bruker Corp. | 15 | 0 | 2 | 0 | €41.24 | €45.57 | 10.487% |
| West Pharmaceutical Services Inc. | 14 | 0 | 0 | 0 | €241.00 | €299.29 | 24.185% |